---
layout: default
title: Naftifine
description: "Naftifine 的老藥新用潛力分析。最高證據等級 L1，包含 8 個預測適應症。查看 AI 預測與臨床證據完整報告。"
parent: 高證據等級 (L1-L2)
nav_order: 109
evidence_level: L3
indication_count: 8
---

# Naftifine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
證據等級: <strong>L1</strong> | 預測適應症: <strong>8</strong> 個
</p>

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Naftifine：從 皮膚黴菌病 到 皮膚念珠菌病

## 一句話總結

<p class="key-answer" data-question="Naftifine 可以用於治療什麼新適應症？">
Naftifine（萘替芬）是一種烯丙胺類局部抗黴菌藥，用於治療皮膚黴菌感染。TxGNN 模型預測它對**皮膚念珠菌病 (cutaneous candidiasis)** 和**花斑癬 (pityriasis versicolor)** 有治療效果，這些預測與其已核准適應症高度一致，有充分文獻支持。
</p>


## 快速總覽

| 項目 | 內容 |
|------|------|
| 原適應症 | 皮膚黴菌病、表皮念珠菌病、甲黴菌病、花斑癬 |
| 預測新適應症 | dermatophytosis of groin and perianal area、tinea pedis、tinea corporis、cutaneous candidiasis、Majocchi granuloma、ectothrix infectious disease、pityriasis versicolor、endothrix infectious disease |
| TxGNN 預測分數 | 99.84% (皮膚念珠菌病), 99.68% (花斑癬) |
| 證據等級 | L1 |
| 台灣上市 | 已上市 |
| 許可證數 | 多張 |
| 建議決策 | Validate |






## 預測適應症詳細分析

<details class="indication-section" open>
<summary>
<span class="indication-name">1. cutaneous candidiasis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.84%</span> <span class="primary-badge">主要分析</span>
</summary>
<div class="indication-content">

<h3>為什麼這個預測合理？</h3>

<p><p class="key-answer" data-question="這個藥物的作用機轉是什麼？"></p>
<p>Naftifine 通過抑制角鯊烯環氧化酶（squalene epoxidase），阻斷麥角固醇合成，破壞真菌細胞膜完整性。</p>
<p></p></p>

<p><div class="key-takeaway"></p>
<p>此預測基於藥物的作用機轉，與現有臨床證據方向一致。</p>

<h3>臨床試驗</h3>

<p>目前無針對此特定適應症的臨床試驗登記。</p>

<h3>相關文獻</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18346400/" target="_blank">18346400</a></td><td>2008</td><td>Article</td><td>Journal of cutaneous medicine </td><td>Naftifine: a review.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1723367/" target="_blank">1723367</a></td><td>1991</td><td>Article</td><td>Drugs</td><td>Naftifine. A review of its antimicrobial activity and therapeutic use in superfi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3048914/" target="_blank">3048914</a></td><td>1988</td><td>Article</td><td>Cutis</td><td>Naftifine cream in the treatment of cutaneous candidiasis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24196340/" target="_blank">24196340</a></td><td>2013</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>Optimizing topical antifungal therapy for superficial cutaneous fungal infection...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18840006/" target="_blank">18840006</a></td><td>2008</td><td>Article</td><td>Drugs</td><td>Topical fenticonazole in dermatology and gynaecology: current role in therapy.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10439936/" target="_blank">10439936</a></td><td>1999</td><td>Article</td><td>Drugs</td><td>Terbinafine. An update of its use in superficial mycoses.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6388169/" target="_blank">6388169</a></td><td>1984</td><td>Article</td><td>Zeitschrift fur Hautkrankheite</td><td>[Multicenter double-blind contralateral comparison of naftifin and clotrimazole ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2620916/" target="_blank">2620916</a></td><td>1989</td><td>Article</td><td>Giornale italiano di dermatolo</td><td>[Evaluation of the efficacy of a new antimycotic molecule for topical use: nafti...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20677526/" target="_blank">20677526</a></td><td>2010</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>Naftifine, a topical allylamine.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. Majocchi granuloma</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.69%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23278484/" target="_blank">23278484</a></td><td>2013</td><td>Article</td><td>Pediatric dermatology</td><td>Impetigo-like tinea faciei around the nostrils caused by Arthroderma vanbreusegh...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. ectothrix infectious disease</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.69%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. pityriasis versicolor</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.68%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（8 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10439936/" target="_blank">10439936</a></td><td>1999</td><td>Article</td><td>Drugs</td><td>Terbinafine. An update of its use in superficial mycoses.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18840006/" target="_blank">18840006</a></td><td>2008</td><td>Article</td><td>Drugs</td><td>Topical fenticonazole in dermatology and gynaecology: current role in therapy.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22165042/" target="_blank">22165042</a></td><td>2011</td><td>Article</td><td>Skinmed</td><td>An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3531847/" target="_blank">3531847</a></td><td>1986</td><td>Article</td><td>Mykosen</td><td>Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24196340/" target="_blank">24196340</a></td><td>2013</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>Optimizing topical antifungal therapy for superficial cutaneous fungal infection...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11952303/" target="_blank">11952303</a></td><td>2002</td><td>Article</td><td>Journal of the European Academ</td><td>Pityriasis versicolor resembling pityriasis rotunda.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2620916/" target="_blank">2620916</a></td><td>1989</td><td>Article</td><td>Giornale italiano di dermatolo</td><td>[Evaluation of the efficacy of a new antimycotic molecule for topical use: nafti...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8370053/" target="_blank">8370053</a></td><td>1993</td><td>Article</td><td>Casopis lekaru ceskych</td><td>[Naftifin--laboratory and clinical experience with a new antimycotic from the al...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. endothrix infectious disease</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.65%</span>
</summary>
<div class="indication-content">

<h3>臨床試驗（1 項）</h3>

<table>
<thead>
<tr><th>試驗編號</th><th>階段</th><th>狀態</th><th>人數</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02658292" target="_blank">NCT02658292</a></td><td>PHASE2</td><td>WITHDRAWN</td><td>0</td><td>A Double-Blind, Randomized, Vehicle-Control, Multicenter Study to Evaluate the E...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. dermatophytosis of scalp or beard</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.65%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（20 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34934294/" target="_blank">34934294</a></td><td>2021</td><td>Article</td><td>International journal of trich</td><td>Beard Reconstruction.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34984089/" target="_blank">34984089</a></td><td>2021</td><td>Article</td><td>Indian journal of plastic surg</td><td>Beard and Moustache Reconstruction.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37510908/" target="_blank">37510908</a></td><td>2023</td><td>Article</td><td>Journal of clinical medicine</td><td>Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38106958/" target="_blank">38106958</a></td><td>2023</td><td>Article</td><td>International journal of psych</td><td>Stress, a Brief Update.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38936998/" target="_blank">38936998</a></td><td>2024</td><td>Article</td><td>Facial plastic surgery clinics</td><td>Facial Hair in Hair Restoration Surgery: Beard Transplantation and Beard-To-Scal...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17232589/" target="_blank">17232589</a></td><td>1903</td><td>Article</td><td>Journal of anatomy and physiol</td><td>The Germ-Cells.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39492201/" target="_blank">39492201</a></td><td>2022</td><td>Article</td><td>Facial plastic surgery clinics</td><td>Hair Restoration in the Ethnic Patient.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32716531/" target="_blank">32716531</a></td><td>2020</td><td>Article</td><td>AORN journal</td><td>Clinical Issues-August 2020.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32541711/" target="_blank">32541711</a></td><td>2020</td><td>Article</td><td>British dental journal</td><td>Beards and masks.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32473165/" target="_blank">32473165</a></td><td>2020</td><td>Article</td><td>Developmental biology</td><td>Long-lived zebrafish Rohon-Beard cells.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36487685/" target="_blank">36487685</a></td><td>1874</td><td>Article</td><td>Hall&#x27;s journal of health</td><td>Beards.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37251589/" target="_blank">37251589</a></td><td>2023</td><td>Article</td><td>Evolution letters</td><td>The role of recognition error in the stability of green-beard genes.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40642854/" target="_blank">40642854</a></td><td>2025</td><td>Article</td><td>Aerospace medicine and human p</td><td>Beard Length and the Efficacy of an Aviator Oxygen Mask.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34912672/" target="_blank">34912672</a></td><td>2021</td><td>Article</td><td>World journal of plastic surge</td><td>Head and Neck Restoration in Scar Alopecia: Hair Transplantation in Scalp, Eyebr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34984086/" target="_blank">34984086</a></td><td>2021</td><td>Article</td><td>Indian journal of plastic surg</td><td>Using Nonscalp Hair in Scalp Hair Restoration-Theory and Execution.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36089697/" target="_blank">36089697</a></td><td>2023</td><td>Article</td><td>The Journal of craniofacial su</td><td>Hair-Bearing Expanded Scalp Flap for Total Beard Reconstruction in Patients With...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26942473/" target="_blank">26942473</a></td><td>2016</td><td>Article</td><td>Orthopedics</td><td>To Beard or Not to Beard? Bacterial Shedding Among Surgeons.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34146585/" target="_blank">34146585</a></td><td>2021</td><td>Article</td><td>Mathematical biosciences</td><td>Quantitative analysis of mitochondrial ATP synthesis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38530738/" target="_blank">38530738</a></td><td>2024</td><td>Article</td><td>IEEE transactions on pattern a</td><td>Multi-Label Conditional Generation From Pre-Trained Models.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19116220/" target="_blank">19116220</a></td><td>2008</td><td>Article</td><td>Integrative cancer therapies</td><td>The life and times of John Beard, DSc (1858-1924).</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. superficial mycosis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.63%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（20 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37355825/" target="_blank">37355825</a></td><td>2023</td><td>Article</td><td>The Journal of the Association</td><td>Naftifine: A Topical Allylamine for Superficial Dermatophytosis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18346400/" target="_blank">18346400</a></td><td>2008</td><td>Article</td><td>Journal of cutaneous medicine </td><td>Naftifine: a review.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1723367/" target="_blank">1723367</a></td><td>1991</td><td>Article</td><td>Drugs</td><td>Naftifine. A review of its antimicrobial activity and therapeutic use in superfi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25502847/" target="_blank">25502847</a></td><td>2015</td><td>Article</td><td>Mycopathologia</td><td>Generalized superficial mycosis caused by Trichophyton raubitschekii in China: c...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33517791/" target="_blank">33517791</a></td><td>2021</td><td>Article</td><td>Drug delivery</td><td>Development, optimization and characterization of nanoemulsion loaded with clove...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24719057/" target="_blank">24719057</a></td><td>2014</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>What is new in fungal pharmacotherapeutics?</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24196340/" target="_blank">24196340</a></td><td>2013</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>Optimizing topical antifungal therapy for superficial cutaneous fungal infection...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26895366/" target="_blank">26895366</a></td><td>2016</td><td>Article</td><td>Journal of the American Podiat</td><td>Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25090020/" target="_blank">25090020</a></td><td>2014</td><td>Article</td><td>The Cochrane database of syste</td><td>Topical antifungal treatments for tinea cruris and tinea corporis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10439936/" target="_blank">10439936</a></td><td>1999</td><td>Article</td><td>Drugs</td><td>Terbinafine. An update of its use in superficial mycoses.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26461833/" target="_blank">26461833</a></td><td>2015</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>New Topical Therapeutic Options in the Management of Superficial Fungal Infectio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8996257/" target="_blank">8996257</a></td><td>1997</td><td>Article</td><td>Journal of the American Academ</td><td>Childhood white superficial onychomycosis caused by Trichophyton rubrum: report ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18840006/" target="_blank">18840006</a></td><td>2008</td><td>Article</td><td>Drugs</td><td>Topical fenticonazole in dermatology and gynaecology: current role in therapy.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35244863/" target="_blank">35244863</a></td><td>2022</td><td>Article</td><td>Mycopathologia</td><td>A Special Tinea Nigra Caused by Curvularia lunata: Case Report and Literature Re...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26151784/" target="_blank">26151784</a></td><td>2015</td><td>Article</td><td>Journal of drugs in dermatolog</td><td>An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Nafti...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8118161/" target="_blank">8118161</a></td><td>1993</td><td>Article</td><td>Archives of medical research</td><td>New topical antifungal drugs.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7619094/" target="_blank">7619094</a></td><td>1994</td><td>Article</td><td>Journal of the American Academ</td><td>Antifungal agents: an overview. Part II.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1550968/" target="_blank">1550968</a></td><td>1992</td><td>Article</td><td>Dermatology (Basel, Switzerlan</td><td>Preclinical data and mode of action of amorolfine.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22165042/" target="_blank">22165042</a></td><td>2011</td><td>Article</td><td>Skinmed</td><td>An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32232786/" target="_blank">32232786</a></td><td>2020</td><td>Article</td><td>Infection</td><td>Unusual dermatomycoses caused by Nannizzia nana: the geophilic origin of human i...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. tinea profunda</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.57%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23278484/" target="_blank">23278484</a></td><td>2013</td><td>Article</td><td>Pediatric dermatology</td><td>Impetigo-like tinea faciei around the nostrils caused by Arthroderma vanbreusegh...</td></tr>
</tbody>
</table>

</div>
</details>


## 台灣上市資訊

| 許可證號 | 品名 | 劑型 | 核准適應症 |
|---------|------|------|-----------|
| 多張許可證 | 鹽酸萘替芬 | 乳膏/溶液 | 皮膚真菌病、表皮念珠菌病、甲黴菌病、花斑癬 |

## 安全性考量

**常見副作用：**
- 局部灼熱感（6.8%）
- 局部刺激
- 皮膚乾燥
- 紅斑

**禁忌症：**
- 對 naftifine 或其他烯丙胺類藥物過敏

**使用注意：**
- 僅供外用
- 避免接觸眼睛和黏膜
- 如出現明顯刺激應停藥

## 結論與下一步

**決策：Validate**

**理由：**
TxGNN 預測的「皮膚念珠菌病」和「花斑癬」實際上已是 naftifine 在台灣的核准適應症（「表皮念珠菌病」和「花斑癬」）。文獻提供了充分的療效證據。此預測更多是對現有適應症的確認，而非新發現。

**若要推進需要：**
- 此藥物已被核准用於預測適應症
- 無需額外驗證研究
- 可直接依據仿單使用


---

## 相關藥物報告

- [Ipratropium]({{ "/drugs/ipratropium/" | relative_url }}) - 證據等級 L1
- [Temozolomide]({{ "/drugs/temozolomide/" | relative_url }}) - 證據等級 L1
- [Anastrozole]({{ "/drugs/anastrozole/" | relative_url }}) - 證據等級 L1
- [Icatibant]({{ "/drugs/icatibant/" | relative_url }}) - 證據等級 L1
- [Docetaxel]({{ "/drugs/docetaxel/" | relative_url }}) - 證據等級 L1

---

{% include ai-analysis.html %}

{% include social-share.html %}

## 引用本報告

如需引用本報告，請使用以下格式：

**APA 格式：**
```
TwTxGNN. (2026). Naftifine老藥新用驗證報告. https://twtxgnn.yao.care/drugs/naftifine/
```

**BibTeX 格式：**
```bibtex
@misc{twtxgnn_naftifine,
  title = {Naftifine老藥新用驗證報告},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/naftifine/}
}
```

---

<div class="disclaimer">
<strong>免責聲明</strong><br>
本報告僅供學術研究參考，<strong>不構成醫療建議</strong>。藥物使用請遵循醫師指示，切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
<br><br>
<small>最後審核：2026-02-20 | 審核者：TwTxGNN Research Team</small>
</div>

{% include giscus.html %}
